Statement regarding press spe

RNS Number : 4884Z
Smith & Nephew Plc
14 January 2011
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For immediate release

Date: 14 January 2011

Smith & Nephew plc

Statement regarding press speculation

Smith & Nephew plc ('Smith & Nephew' or 'the Company') notes the continued press speculation in relation to a possible merger or takeover involving the Company.

Smith & Nephew has a long-standing policy of not commenting on press speculation, unless there is a regulatory obligation to do so.  However, exceptionally, Smith & Nephew wishes to clarify that it is not engaged in any discussions which could lead to a merger or a takeover involving the Company.   

Enquiries:

Smith & Nephew                                            +44(0)20 7401 7646

Liz Hewitt

Phil Cowdy                                          

 

Brunswick                                                      +44(0)20 7404 5959              

Jon Coles

Mike Smith                  

 

About Smith & Nephew

 

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics; including Reconstruction, Trauma and Clinical Therapies; Endoscopy; including Sports Medicine; and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

 

Smith & Nephew is dedicated to helping improve people's lives.  The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.  The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide.  Annual sales in 2009 were nearly $3.8 billion.

 

Forward-Looking Statements

 

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution.  Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCFZLFFFFFBBBV
UK 100

Latest directors dealings